CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) (USD $)	Series A Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Retained Earnings (Accumulated Deficit) [Member]	Total
Balances at Dec. 31, 2010		$ 64,382				$ 6,100,528
Balances(in shares) at Dec. 31, 2010	0	64,381,910	57,888,506	(25,000)	(51,827,360)	6,100,528
Employee share-based compensation expense	0	0	1,032,261	0	0	1,032,261
Other share-based compensation expense	0	0	285,154	0	0	285,154
Exercise of stock options	0	490	295,263	0	0	295,753
Exercise of stock options (in shares)		490,000
Warrants (net of $34,733 of offering costs)	0	3,779	3,739,809	0	0	3,743,588
Sale of common stock and warrants (net of $34,733 of offering costs) (in shares)		3,778,321
Shares issued in conjunction with conversion of convertible debt	0	406	406,257	0	0	406,663
Shares issued in conjunction with conversion of convertible debt (in shares)		406,664
Shares issued in conjunction with acquisition of Surgical Biologics, LLC	0	5,250	7,082,250	0	0	7,087,500
Shares issued in conjunction with acquisition of Surgical Biologics, LLC (in shares)		5,250,000
Beneficial conversion feature recognized on convertible debt	0	0	437,500	0	0	437,500
Discount on benefical conversion feature recognized on line of credit	0	0	80,000	0	0	80,000
Net loss for the peiod	0	0	0	0	(7,616,791)	(7,616,791)
Balances at Sep. 30, 2011	$ 0	$ 74,307	$ 71,247,000	$ (25,000)	$ (59,444,151)	$ 11,852,156
Balances (in shares) at Sep. 30, 2011		74,306,895